Profile
ABEO VRTX REGN VRNA ARGX ALNY
Company Name Abeona Therapeutics Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $253.75M $116.06B $76.56B $72.68B $53.66B $52.51B
Employees 0.14K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Vishwas Seshadri Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
ABEO VRTX REGN VRNA ARGX ALNY
Quant Rating Score 4 4 4 1 4 3
Quant Rating Buy Buy Buy Strong Sell Buy Neutral
Trading
ABEO VRTX REGN VRNA ARGX ALNY
Last Close $4.51 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $7.24 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $4.17 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -37.71 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 8.15 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
ABEO VRTX REGN VRNA ARGX ALNY
1 Month Return -16.17 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -34.73 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return -26.07 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return -22.91 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -19.03 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -23.43 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABEO VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.47 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -10.09 % 9.76 % 4.25 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 6.06 % - - -
Growth
ABEO VRTX REGN VRNA ARGX ALNY
Asset Growth 70.2 % 14.15 % 53.91 %
Gross Profit Growth -253.4 % 12.5 % -
Revenue Growth -100 % 8.27 % -
Revenue 3 Year -100 % -13.44 % -15.89 %
Revenue 5 Year - 119.18 % -
Revenue 10 Year -100 % 429.43 % -
EBIT Growth -10.7 % 13.17 % -131.37 %
Net Income Growth -17.62 % 11.61 % -224.78 %
Net Income 3 Yeari Growth Per Share 92.8 % -46.47 % -148.34 %
Net Income 5 Yeari Growth Per Share 95.9 % 111.07 % 25.82 %
Net Income 10 Yeari Growth Per Share 99.89 % 1232.49 % -35.51 %
Operating Income Growth -36.23 % -8.23 % -133.02 %
Operating Cash Flow Growth (CFG) -51.36 % -3.78 % -143.33 %
Operating 3 Year CFG 91.82 % -38.85 % -170.73 %
Operating 5 Year CFG 95.63 % 84.11 % 54.81 %
Operating 10 Year CFG 98.35 % 517.51 % 40.15 %
EPS Growth 38.74 % 10.39 % -214.81 %
EPS Diluted Growth 38.74 % 10.27 % -208.93 %
Book Value Per Share 54.69 % 11.76 % -22.82 %
Share Holder 3 Year Equity Growth Per Share -90.03 % 53.21 % 1.82 %
Share Holder 5 Year Equity Growth Per Share -98.79 % 167.88 % -24.45 %
Share Holder 10 Year Equity Growth Per Share -99.57 % 1113.59 % -71.86 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share -100 % - -
Debt Growth 326.81 % 0.06 % 139.05 %
Free Cash Flow Growth -56.56 % -0.08 % -144.48 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
ABEO VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 26.79 % 86.28 % 85.39 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM 35.63 % 14.78 % 11.4 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM 78.38 % 19.62 % 15.31 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -39.83 % 19.59 % 10.32 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 99.62 % 82.61 % 88.98 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM -99.35 % 111.4 % 139.5 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -1605.73 % 34.06 % 25.89 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -310.83 % 202.64 % 187.43 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM 3.21 6.02 2.51 1.93 1.91 3.33
Payables Turnover TTM 0.24 0.4 2.3 2.37 0.9 4.37
Inventory Turnover TTM 0.29 0.99 0.64 0.94 2.26 6.82
Fixed Asset Turnover TTM 35.93 % 388.59 % 284.82 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 2.24 % 47.15 % 35.47 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -1.38 14.55 48.94 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -1.52 13.06 40.09 -0.85 5.58 1.68
Cash Per Share TTM 381.84 % 2459.7 % 8148.65 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -1446.01 % 31.71 % 35.59 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 109.91 % 89.76 % 81.92 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -310.83 % 202.64 % 187.43 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -3.08 34.78 18.43 -995.27 126.92 237.2
Price To Operating Cash Flows Ratio TTM -3.67 31.09 15.15 -126.33 144.96 196.51
Price Cash Flow Ratio TTM -3.67 31.09 15.15 -126.33 144.96 196.51
Income Statement (TTM)
ABEO VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.2B $0.03B $2.19B $2.25B
Gross Profit $-0B $9.49B $12.23B $0.03B $1.96B $1.92B
Gross Profit Ratio 0% 86.11% 86.13% 93.89% 89.62% 85.62%
EBITDA $-0.06B $0.49B $5.32B $-0.12B $0.11B $-0.18B
Net Income $-0.06B $-0.54B $4.41B $-0.14B $0.83B $-0.28B
EPS Diluted -1.55 -2.08 38.34 -1.73 12.78 -2.18
Balance Sheet (MRQ)
ABEO VRTX REGN VRNA ARGX ALNY
Long Term Debt $0.02B $1.66B $2.7B $0.12B $0.03B $2.59B
Total Liabilities $0.06B $6.12B $8.41B $0.27B $0.7B $4.17B
Total Equity $0.04B $16.41B $29.35B $0.2B $5.5B $0.07B
Total Investments $0.07B $6.65B $15.42B $0.02B $1.93B $1.73B
Total Debt $0.02B $1.75B $2.7B $0.12B $0.04B $2.74B
Total Assets $0.11B $22.53B $37.76B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
ABEO VRTX REGN VRNA ARGX ALNY
Net Income $-0.06B $-0.54B $4.41B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.62B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.06B $-0.49B $4.42B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.76B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 28.8501
AARD Aardvark Therapeutics, Inc. Common Stock 13.88
ABCL AbCellera Biologics Inc. 3.445
ABCM Abcam plc 23.99
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.0867
ABPWW 0.02
ABSI Absci Corporation 3.5599
ABUS Arbutus Biopharma Corporation 4.6254
ABVC ABVC BioPharma, Inc. 2.1
ABVX Abivax SA American Depositary Shares 111.439
ACAD ACADIA Pharmaceuticals Inc. 26.7937
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.4708
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.43
ACIU AC Immune SA 3.325
ACLX Arcellx, Inc. 66.41
ETFs With Exposure to ABEO
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00798 249.51
VTI Vanguard Total Stock Market Index Fund 0.00037 333.78
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00075 147.6
IWN iShares Russell 2000 Value ETF 0.00178 184.25
IWO iShares Russell 2000 Growth ETF 0.01433 326.51
VXF Vanguard Extended Market Index Fund 0.00322 210.74
HDG ProShares Hedge Replication ETF 0.00115396 51.735
UWM ProShares Ultra Russell2000 0.0058192 48.6071
VTHR Vanguard Russell 3000 Index Fund 0.00033 299.125
IWC iShares Micro-Cap ETF 0.05088 160.22
URTY ProShares UltraPro Russell2000 0.00470369 55.845
VTWV Vanguard Russell 2000 Value Index Fund 0.00084 163.35
EES WisdomTree U.S. SmallCap Earnings Fund 0.08225 57.845
VFMO Vanguard U.S. Momentum Factor ETF 0.0333 191.307
VTWG Vanguard Russell 2000 Growth Index Fund 0.01388 239.105
VTWO Vanguard Russell 2000 Index Fund 0.00748 101.21
XAW.TO iShares Core MSCI All Country World ex Canada Index ETF 0 50.93
XUU.TO iShares Core S&P U.S. Total Market Index ETF 0 68.51
XUH.TO iShares Core S&P U.S. Total Market Index ETF (CAD-Hedged) 0 54.55
XTR.TO iShares Diversified Monthly Income ETF 0 11.68
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0.01 47.57
VMO.TO Vanguard Global Momentum Factor ETF 0.02968 78.26
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00043 114.03
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0.00043 114.01
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00026 53.27
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00026 53.26
VBINX Vanguard Balanced Index Fund Investor Shares 0.00026 53.26
IEIH iShares Evolved U.S. Innovative Healthcare ETF 0 34.1348
XBAL.TO iShares Core Balanced ETF Portfolio 0 33.34
XCNS.TO iShares Core Conservative Balanced ETF Portfolio 0 25.32
XEQT.TO iShares Core Equity ETF Portfolio 0 39.68
XGRO.TO iShares Core Growth ETF Portfolio 0 34.76
XINC.TO iShares Core Income Balanced ETF Portfolio 0 21.25
DFAT Dimensional U.S. Targeted Value ETF 0 60.185
DFAS Dimensional U.S. Small Cap ETF 0.00020616 70.505
DFAC Dimensional U.S. Core Equity 2 ETF 0 39.385
VTSAX Vanguard Total Stock Market Index Fund 0.00037 163.19
R2US.L SPDR Russell 2000 US Small Cap UCITS ETF 0.008641 73.2
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00322 160.77
VITSX Vanguard Total Stock Market Index Fund 0.00037 163.22
XRS2.F Xtrackers Russell 2000 UCITS ETF 0.0095387 318.35
IBRN iShares Neuroscience and Healthcare ETF 0.51881 31.78
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000165995 16.34
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00322 160.78
XRSG.L Xtrackers (IE) Public Limited Company - Xtrackers Russell 2000 UCITS ETF 0.0095387 27695
XRSU.L Xtrackers (IE) Public Limited Company - Xtrackers Russell 2000 UCITS ETF 0.0095387 371.775
ZPRR.DE SPDR Russell 2000 US Small Cap UCITS ETF 0.008641 62.16
R2SC.L SPDR Russell 2000 US Small Cap UCITS ETF 0.008641 54.505
XRS2.DE Xtrackers Russell 2000 UCITS ETF 0.0095387 315.85
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
JKJ iShares Morningstar Small-Cap ETF 0 231.193
JKL iShares Morningstar Small-Cap Value ETF 0 172.726
SURI Simplify Propel Opportunities ETF 3.4356 17.09
VTS.AX Vanguard US Total Market Shares Index ETF 0.00036 503.49
VEMPX Vanguard Extended Market Index InstlPlus 0.00322 396.75
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00037 306.19
RSSL Global X Funds 0.01 98.265
LITL Simplify Exchange Traded Funds 0.596248 30.2366
Unlock